ClinicalTrials.Veeva

Menu

Evolution of Cochleovestibular Schwannomas

U

University Hospital, Strasbourg, France

Status

Unknown

Conditions

Schwannoma

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Investigators want to know the natural history of the vestibular schwannomas: increasing, decreasing or stability, by monitoring more than 3 MRIs during a span of more than 2 years. They will obtain 3 groups: the volume increasing schwannomas which will be the most important group, the schwannomas that will be stable and a small group where the schwannomas will decrease.

The secondary purpose is that the investigators want to know the threshold values: a minimum volume under which we are sure that the schwannoma will not increase, a maximum value where it will increase and if its evolution can be correlated to clinical or radiological criteria.

Enrollment

140 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age over 18 years
  • having a typical vestibular schwannoma diagnosis during the first MRI, having a minimum of 3 internal auditory canal MRIs on the same machine (Signa HDxt, General Electric, Strasbourg, France) ) at the Hôpitaux Universitaires de Strasbourg
  • patients consenting to participate

Exclusion criteria

  • intra-labyrinthical extension
  • treatment before the 3 MRIs
  • no injection of gadolinium
  • atypical diagnosis

Trial contacts and locations

1

Loading...

Central trial contact

Aïna VENKATASAMY, MD; Saïd CHAYER, PhD, HDR

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems